Stockreport

FDA OKs Akorn's diclofenac sodium topical gel [Seeking Alpha]

AKORN  (AKRX) 
Last akorn earnings: 10/31 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.akorn.com
PDF The FDA approves Akorn's (NASDAQ: AKRX ) diclofenac sodium topical gel 1%, a generic version of GlaxoSmithKline's (NYSE: GSK ) Voltaren, for the relief of pain [Read more]